REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,635,732 | +5.7% | 420,366 | +2.1% | 0.00% | +50.0% |
| Q2 2023 | $11,008,722 | +73.7% | 411,541 | +40.6% | 0.00% | +100.0% |
| Q1 2023 | $6,337,954 | +2.6% | 292,611 | +12.9% | 0.00% | 0.0% |
| Q4 2022 | $6,175,764 | +21.5% | 259,268 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $5,085,000 | +31.8% | 257,865 | +30.2% | 0.00% | 0.0% |
| Q2 2022 | $3,859,000 | -42.2% | 198,011 | -24.4% | 0.00% | 0.0% |
| Q1 2022 | $6,679,000 | -1.2% | 261,808 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $6,759,000 | -8.4% | 268,557 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $7,379,000 | +0.1% | 268,215 | +15.5% | 0.00% | 0.0% |
| Q2 2021 | $7,371,000 | +13.2% | 232,234 | +63.7% | 0.00% | 0.0% |
| Q1 2021 | $6,511,000 | +19.7% | 141,902 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $5,440,000 | +20.9% | 137,409 | +6.2% | 0.00% | 0.0% |
| Q3 2020 | $4,501,000 | +154.7% | 129,360 | +131.2% | 0.00% | – |
| Q2 2020 | $1,767,000 | +106.4% | 55,956 | +43.2% | 0.00% | – |
| Q1 2020 | $856,000 | – | 39,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |